Friday, July 10, 2026

Drug profile · INN

amrubicin hydrochloride

amrubicin hydrochloride is a dna topoisomerase ii alpha inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — amrubicin hydrochloride
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

amrubicin hydrochloride is a dna topoisomerase ii alpha inhibitor.

Key facts

INN amrubicin hydrochloride
Mechanism DNA topoisomerase II alpha inhibitor
Target DNA topoisomerase 2-alpha

Mechanism of action

DNA topoisomerase II alpha inhibitor

Primary target: DNA topoisomerase 2-alpha

Approval history

Authority Status Date
NMPA clinical trials

Related & competitor drugs

  1. etoposide phosphate DNA topoisomerase II alpha inhibitor

Frequently asked questions

What is amrubicin hydrochloride?

amrubicin hydrochloride is a dna topoisomerase ii alpha inhibitor.